Latest filing published 17 Jan 2023 for Lexston Life Sciences Corp., €3,824.
This profile gathers the share dealings of Jagdip Bal in Lexston Life Sciences Corp. We count 9 filings; the first trade dates from 17 June 2021 and the latest from 17 January 2023.
The open-market record is one-sided, with 8 purchases worth €17k and not one sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. 2023 to date brings 3 purchases and no sales.
Half of the purchases are above €1,635 and half below. No cluster: in 7 purchases, no other insider of the company bought within 30 days.
On 17 January 2023 came the latest disclosure, an open-market purchase for €3,824 in Lexston Life Sciences Corp. Most trades are made public on the day they happen. This delay matters because a trade only becomes useful information once it is public. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 of 9 declarations